Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Sanofi SA Add to portfolio

STX:SAN, Jan 20, 12:43 UTC

Latest STX:SAN News

Filter your feed

Apply Filter

Today


News

Banco Santander (SAN) Given a €7.00 Price Target by JPMorgan Chase & Co.

SAN SAN

Banco Santander (SAN) Given a €7.00 Price Target at JPMorgan Chase & Co. Deutsche Bank set a €6.60 ($7.86) target price on Banco Santander and gave the stock a buy rating in a report on Wednesday, October 4th. set a €6.10 ($7.26) price target on Banco Santander and gave the company a neutral rating in a report on Monday, September 25th. Royal Bank of Canada set a €5.80 ($6.90) price target on Banco Santander and gave the company a neutral rating in a report on Wednesday, December 6th.

Read Full Details

Topics:
  • Business
  • Financial

Yesterday


News

What’s Propelling Sanofi (NYSE:SNY) After Lower Shorts Reported?

SAN

The stock of Sanofi (NYSE:SNY) registered a decrease of 3.45% in short interest. SNY’s total short interest was 1.74 million shares in January as published by FINRA. As per Friday, December 1, the company rating was downgraded by Morgan Stanley. The stock has “Hold” rating by HSBC on Wednesday, August 30. As per Friday, April 21, the company rating was maintained by JP Morgan.

Read Full Details

Story Sources

kldaily.com
Topics:
  • Business
  • Health
  • Financial
News

Sanofi (NYSE:SNY) Stock Is Shorted Less – Weekly Register

SAN

The stock of Sanofi (NYSE:SNY) registered a decrease of 3.45% in short interest. SNY’s total short interest was 1.74M shares in January as published by FINRA. The stock of Sanofi (NYSE:SNY) earned “Underweight” rating by Morgan Stanley on Friday, December 1. Berenberg downgraded the stock to “Hold” rating in Thursday, May 11 report. com and their article: “5 Reasons Why Sanofi SA (ADR) (SNY) is a Good Stock to Buy Now” published on April 12, 2017 as well as Investorplace.

Read Full Details

Story Sources

weeklyregister.com
Topics:
  • Business
  • Health
  • Financial
News

Sanofi (NYSE:SNY) Could Improve Your Long Portfolio After Less Shorts Reported

SAN

The stock of Sanofi (NYSE:SNY) registered a decrease of 3.45% in short interest. SNY’s total short interest was 1.74 million shares in January as published by FINRA. The stock of Sanofi (NYSE:SNY) has “Neutral” rating given on Tuesday, September 13 by BNP Paribas. Cowen & Co maintained Sanofi (NYSE:SNY) on Friday, October 13 with “Hold” rating.

Read Full Details

Story Sources

finnewsdaily.com
Topics:
  • Business
  • Health
  • Financial
News

Is Buying Sanofi (NYSE:SNY), Having Lower Short Interest a Winning Strategy?

SAN

The stock of Sanofi (NYSE:SNY) registered a decrease of 3.45% in short interest. SNY’s total short interest was 1.74M shares in January as published by FINRA. The stock of Sanofi (NYSE:SNY) has “Underweight” rating given on Friday, December 1 by Morgan Stanley. The rating was downgraded by HSBC to “Reduce” on Friday, April 7. More notable recent Sanofi (NYSE:SNY) news were published by: Investorplace.

Read Full Details

Story Sources

bzweekly.com
Topics:
  • Business
  • Health
  • Financial
News

Sanofi’s (SNY) Neutral Rating Reaffirmed at UBS Group – StockNewsTimes

SAN

reiterated a neutral rating on shares of Sanofi in a research note on Thursday, December 14th. Bank of America lowered Sanofi from a buy rating to a neutral rating in a research note on Wednesday, December 6th. BlackRock Inc. now owns 2,235,422 shares of the company’s stock valued at $107,100,000 after acquiring an additional 720,523 shares during the last quarter. UBS Asset Management Americas Inc. now owns 75,475 shares of the company’s stock valued at $3,616,000 after acquiring an additional 13,959 shares during the last quarter.

Read Full Details

Story Sources

stocknewstimes.com
Topics:
  • Business
  • Financial
News

Texas Instruments Incorporated (TXN) Mix Thrust In Focus with, Sanofi (SNY)

SAN TXN

Looking on other side, Forward Price to Earnings ratio of TXN persists on 25.57. The firm has price to earnings growth of 2.45, which is a valuation metric for determining relative trade-off among price of a stock. Looking forward to the ratio analysis, the co has price to earnings ratio of 26.51, which is indicating if firm is fluctuating between 15 and 25 than it lies on average position; The firm attains price to earnings ratio of 20.43. The price to current year EPS has 1.40%. The price volatility’s Average True Range for 14 days was 0.52. On these bases, analysts would recommend this stock as an “Active Spinning Stocks.

Read Full Details

Story Sources

investingbizz.com
Topics:
  • Business
  • Financial
News

Nord/LB Reiterates Neutral Rating for Sanofi (SNY) – Week Herald

SAN

restated a “neutral” rating on shares of Sanofi in a research note on Thursday, December 14th. Sanofi (NYSE:SNY)‘s stock had its “neutral” rating reiterated by equities research analysts at Nord/LB in a report released on Tuesday, January 2nd. Fisher Asset Management LLC now owns 14,082,257 shares of the company’s stock worth $701,156,000 after purchasing an additional 443,799 shares during the period. Parametric Portfolio Associates LLC now owns 1,558,400 shares of the company’s stock worth $77,593,000 after purchasing an additional 101,718 shares during the period.

Read Full Details

Story Sources

weekherald.com
Topics:
  • Business
  • Financial
News

Southpoint Capital Advisors LP Has Boosted Its Sanofi (SNY) Stake by $39.20 Million; Valuation Rose; Lmr Partners Llp Upped Its Holding in Sl Green Realty (SLG) by $1.18 Million - Flint Daily

SAN SLG

Lmr Partners Llp who had been investing in Sl Green Realty Corp for a number of months, seems to be bullish on the $9.32B market cap company. Southpoint Capital Advisors Lp bought 800,000 shares as the company’s stock rose 14.25% with the market. The stock of SL Green Realty Corp. (NYSE:SLG) has “Buy” rating given on Friday, October 23 by TheStreet. The stock of SL Green Realty Corp. (NYSE:SLG) has “Hold” rating given on Tuesday, September 8 by Evercore.

Read Full Details

Story Sources

flintdaily.com
Topics:
  • Business
  • Financial
News

Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee

SAN

Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee. Paris, France -January 19, 2018 - Sanofi has appointed Dominique Carouge as Executive Vice President Head of Business Transformation, effective February 15, 2018. In this role, Mr. Carouge will be in charge of accelerating the transformation of the Company and will be a member of the Executive Committee. Sanofi Forward-Looking Statements. com.

Read Full Details

Topics:
  • Business
  • Health
  • Financial